{"id":311283,"date":"2019-12-30T22:03:00","date_gmt":"2019-12-31T06:03:00","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-xbiotech-says-bermekimab-sale-to-jj-closes-acceleron-pharma-teams-up-with-fulcrum-therapeutics\/"},"modified":"2019-12-30T22:03:37","modified_gmt":"2019-12-31T06:03:37","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-xbiotech-%e5%ae%8c%e6%88%90%e5%90%91%e5%bc%b7%e7%94%9f%e5%87%ba%e5%94%ae-bermekimab-acceleron-pharma-%e8%88%87-fulcrum-therapeutics-%e5%90%88","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-xbiotech-%e5%ae%8c%e6%88%90%e5%90%91%e5%bc%b7%e7%94%9f%e5%87%ba%e5%94%ae-bermekimab-acceleron-pharma-%e8%88%87-fulcrum-therapeutics-%e5%90%88\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014XBiotech\u5b8c\u6210\u5411\u5f37\u751f\u51fa\u552ebermekimab\uff0cAcceleron Pharma\u8207Fulcrum Therapeutics\u5408\u4f5c"},"content":{"rendered":"<h2>Biotech\u5b8c\u6210\u5411\u5f37\u751f\u51fa\u552e<strong>bermekimab<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=XBIT\">XBiotech(NASDAQ:XBIT)<\/a>\u5728\u76e4\u5f8c\u4ea4\u6613\u4e2d\u4e0a\u6f321.8%\uff0c\u6b64\u524d\u6709\u6d88\u606f\u7a31\u8a72\u516c\u53f8\u5df2\u5c07\u5176\u6297\u9ad4bermekimab\u51fa\u552e\u7d66\u5f37\u751f\u516c\u53f8\u7684Janssen Biotech\u90e8\u9580\u3002<\/li>\n<li>XBIT\u8868\u793a\uff0c\u5b83\u7372\u5f97\u4e867.5\u5104\u7f8e\u5143\u4ed8\u6b3e\uff0c\u5982\u679cJanssen\u5c0b\u6c42\u76ae\u819a\u75c5\u5b78\u4ee5\u5916\u7684bermekimab\u9069\u61c9\u75c7\uff0c\u5247\u5728\u5b8c\u6210\u67d0\u4e9b\u5546\u696d\u5316\u6388\u6b0a\u5f8c\u53ef\u80fd\u9084\u6703\u518d\u7372\u5f976\u5104\u7f8e\u5143\u4ed8\u6b3e\u3002<\/li>\n<\/ul>\n<h2><strong>Acceleron Pharma<\/strong><strong>\u8207<\/strong><strong>Fulcrum Therapeutics<\/strong><strong>\u5408\u4f5c\u6cbb\u7642\u80ba\u90e8\u75be\u75c5<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=XLRN\">Acceleron Pharma\uff08XLRN-0.7%\uff09<\/a>\u8207Fulcrum Therapeutics\uff08FULC\uff09\u7c3d\u7f72\u4e86\u4e00\u9805\u5408\u4f5c\u548c\u8a31\u53ef\u5354\u8b70\uff0c\u65e8\u5728\u9452\u5b9a\u8a2d\u8a08\u7528\u65bc\u8abf\u7bc0\u8207\u672a\u516c\u958b\u7684\u80ba\u90e8\u75be\u75c5\u6307\u5f81\u76f8\u95dc\u7684\u7279\u5b9a\u9014\u5f91\u7684\u5c0f\u5206\u5b50\u3002<\/li>\n<li>\u8a72\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5c07\u5229\u7528Fulcrum\u7684\u5c08\u696d\u77e5\u8b58\uff0c\u5229\u7528Acceleron\u5728TGF-\u03b2\u8d85\u5bb6\u65cf\u4fe1\u865f\u8f49\u5c0e\u65b9\u9762\u7684\u5c08\u696d\u77e5\u8b58\u4f86\u78ba\u5b9a\u85e5\u7269\u9776\u6a19\u3002<\/li>\n<li>Acceleron\u5c07\u6709\u6b0a\u4f7f\u7528Fulcrum\u7684\u5c08\u6709\u7522\u54c1\u5f15\u64ce\u548c\u76ee\u6a19\u8b58\u5225\u5e73\u81fa\uff0c\u4e26\u5c07\u8ca0\u8cac\u5df2\u8b58\u5225\u5019\u9078\u85e5\u7269\u7684\u6240\u6709\u958b\u767c\u548c\u5546\u696d\u5316\u6d3b\u52d5\u3002<\/li>\n<\/ul>\n<h2><strong>Urovant<\/strong><strong>\u63d0\u4ea4<\/strong><strong>Vibegron<\/strong><strong>\u7684\u7f8e\u570b\u7533\u8acb<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=UROV\">Urovant Sciences\uff08NASDAQ\uff1aUROV\uff09<\/a>\u5df2\u5411FDA\u63d0\u4ea4\u5176\u71df\u92b7\u7533\u8acb\uff0c\u4ee5\u5c0b\u6c42\u6279\u51c6\u4f7f\u7528\u6bcf\u65e5\u4e00\u6b21\u768475\u6beb\u514b\u5291\u91cf\u7684vibegron\u4f86\u6cbb\u7642\u60a3\u6709\u8180\u80f1\u904e\u5ea6\u6d3b\u52d5\u75c7\u7684\u5c3f\u6025\u548c\u5c3f\u983b\u75c7\u72c0\u3002<\/li>\n<\/ul>\n<h2>Urovant Sciences\u7c4c\u8cc7$3\u5104<\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=UROV\">Urovant Sciences\uff08NASDAQ\uff1aUROV\uff09<\/a>\u5df2\u8207\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85e5\u682a\u5f0f\u6703\u793e\uff08Sumitomo Dainippon Pharma Co.\uff0cLtd.\uff09\u7c3d\u8a02\u4e863\u5104\u7f8e\u5143\u7684\u5b9a\u671f\u8cb8\u6b3e\u5b89\u6392\u3002<\/li>\n<li>\u8a72\u7b46\u8cc7\u91d1\u5c07\u7528\u65bc\u511f\u9084\u73fe\u6709\u50b5\u52d9\uff0c\u70ba\u6b63\u5728\u9032\u884c\u7684\u958b\u767c\u9805\u76ee\u63d0\u4f9b\u8cc7\u91d1\u3002\u5982\u679c\u7372\u5f97FDA\u6279\u51c6\uff0c\u5247\u70bavibegron\u7684\u5546\u696d\u4e0a\u5e02\u63d0\u4f9b\u8cc7\u91d1\uff0c\u4ee5\u53ca\u7528\u65bc\u4e00\u822c\u516c\u53f8\u7528\u9014\u3002<\/li>\n<\/ul>\n<h2>MediPharm Labs\u7372\u52a0\u62ff\u5927\u885b\u751f\u90e8\u7684\u4fee\u8a02\u8a31\u53ef<\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=MEDIF\">MediPharm Labs\uff08OTCQX\uff1aMEDIF\uff09<\/a>\u5df2\u6536\u5230\u52a0\u62ff\u5927\u885b\u751f\u90e8\u7684\u4fee\u8a02\u8a31\u53ef\uff0c\u5141\u8a31\u8a72\u516c\u53f8\u5728\u5b89\u5927\u7565\u7701\u5df4\u88e1\u5e02\u7684\u5c08\u696d\u88fd\u9020\u5de5\u5ee0\u7684\u6700\u8fd1\u64f4\u5efa\u5340\u57df\u4e2d\u958b\u59cb\u751f\u7522\u3002<\/li>\n<li>\u9019\u9805\u4fee\u8a02\u4f7fMediPharm\u7684\u8a31\u53ef\u8a2d\u65bd\u5360\u5730\u9762\u7a4d\u589e\u52a0\u4e86\u7d04\u4e09\u500d\uff0c\u5373\u589e\u52a0\u4e8616,746\u5e73\u65b9\u82f1\u5c3a\uff0c\u7e3d\u9762\u7a4d\u9054\u5230\u7d0425,000\u5e73\u65b9\u82f1\u5c3a\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>XBiotech (NASDAQ:XBIT) +1.8% after-hours following news it closed the sale of its True Human antibody bermekimab to Johnson &amp; Johnson&#8217;s Janssen Biotech unit. Acceleron Pharma (XLRN -0.7%) inks a collaboration and license agreement with Fulcrum Therapeutics (FULC)<\/p>\n","protected":false},"author":9,"featured_media":311277,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644],"class_list":["post-311283","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/311283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=311283"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/311283\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/311277"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=311283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=311283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=311283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}